Nomura Holdings Inc Meridian Bioscience Inc Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$13.8 - $16.8 $169,298 - $206,102	-12,268 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$13.8 - $16.2 $814,200 - $955,800	-59,000 Reduced 82.79%	12,268 $175,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.2 $169,298 - $198,741	12,268 Added 20.79%	71,268 $1 Million
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $793,550 - $846,650	59,000	59,000 $842,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.